Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Heyder, M. Kohler, R. Karimi, B. Levänen, A. Eklund, J. Grunewald, C. M. Sköld, A. Wheelock (Stockholm, Sweden). Alterations of the soluble proteome of airway epithelial cells in COPD. Eur Respir J 2013; 42: Suppl. 57, 1507

Member's Comments

No comment yet.

Related content which might interest you: Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Investigating large and small airway epithelial cell senescence in COPD and bronchiectasis Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Altered airway epithelial cell specification in COPD Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 TSPO a new anti-inflammatory target in the airway of COPD Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Differential bronchial epithelial gene expression in COPD versus controls Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015